Nachrichten, Medien und Veranstaltungen
Erfahren Sie mehr über PPTA. Bleiben Sie über Ereignisse auf dem Laufenden, oder hier klicken um aktuelle Pressemitteilungen und mehr zu lesen.



Kalender
International Plasma Awareness Week (IPAW) 2025
International Plasma Awareness Week (IPAW) 2025
PPTA Plasma Protein Forum 2025
PPTA Plasma Protein Forum 2025
PPTA Business Forum 2025
PPTA Business Forum 2025
Immunoglobulin National Society (IgNS) Annual National Conference
Immunoglobulin National Society (IgNS) Annual National Conference
Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting
Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting
World Orphan and Drug Congress
World Orphan and Drug Congress
Alpha-1 Awareness Month
Alpha-1 Awareness Month
International Primary Immunodeficiencies Congress (IPIC) 2025
International Primary Immunodeficiencies Congress (IPIC) 2025
Neuroscience 2025
Neuroscience 2025
ESID EHA SIOPE Focused Symposium 2025, “The Interplay of Immunology & Haematology”
ESID EHA SIOPE Focused Symposium 2025, “The Interplay of Immunology & Haematology”
American Society of Hematology (ASH) Annual Meeting and Exposition
American Society of Hematology (ASH) Annual Meeting and Exposition
Hemophilia Council of California -- Health Care Access Forum
Hemophilia Council of California -- Health Care Access Forum
National Kawasaki Disease Awareness Day
National Kawasaki Disease Awareness Day
Multifocal Motor Neuropathy Awareness Month
Multifocal Motor Neuropathy Awareness Month
American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Bleeding Disorders Awareness Month
Bleeding Disorders Awareness Month
Liver Coalition – New Treatments in Chronic Liver Disease
Liver Coalition – New Treatments in Chronic Liver Disease
National Primary Immunodeficiency Awareness Month
National Primary Immunodeficiency Awareness Month
Immunology 2026
Immunology 2026
Hemophilia Federation of America (HFA) Symposium
Hemophilia Federation of America (HFA) Symposium
MEDIEN
In unserer Mediathek erfahren Sie mehr über die Arbeit der PPTA und über wichtige Themen in unserer Branche. Sie können auch unsere Social-Media-Seiten besuchen, um über aktuelle Ereignisse auf dem Laufenden zu bleiben.
%201.jpg)
Patient Access to Plasma-Derived Medicines in the U.S.: International Plasma Awareness Week Webinar

The Journey of Plasma-Derived Medicines: From Collection to Care (1 min)

The Journey of Plasma-Derived Medicines: From Collection to Care

Interview with Irene Saugar Gómez, Ph.D., Quality Assessor of biological human medicinal products with the Spanish Agency of Medicines and Medical Devices

PPTA President and CEO Anita Brikman speaks with Grifols Egypt CEO Dr. Magdy Amin

Oksana Muliarchuk - Director of a Ukrainian-Based Network of Plasma Centers

Thomas Kreil, Winner of the Hilfenaus Award

Watch our interview with Prof. Richard Knight as he shares valuable perspectives on immunoglobulins

Patient Stories presented by PPTA

PPTA New Website and Brand Launch

The Brussels Times Hosts Event at the European Parliament

Take a tour of a plasma donation center in Frankfurt, Germany
-%20Day%20One.webp)
2022 International Plasma Protein Congress (IPPC): Day One

The need for a policy change – Plasma donation
-%20Day%20One.jpg)
2022 International Plasma Protein Congress (IPPC): Day Two

Differentiating Plasma from Blood

U.S. Roundtable on Immunoglobulin Use

EU BTC revision – The socioeconomic benefits of plasma-derived medicines

Why is Donating Plasma Important?

Strengthening the EU Blood Directive for patients who need plasma-derived medicines

Meet Amber, a Teacher and Dedicated Plasma Donor

Europe needs to collect more plasma – Improving patient access to plasma-derived medicines

EU BTC revision – Facts about compensating plasma donors
.jpg)
Highlights from the April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)
.jpg)
April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)

“Introduction to the Global Journey of Plasma" webinar

Presentation of the 2020 Robert W. Reilly Award

Presentation of the 2020 Joachim Hilfenhaus Award

Highlights from the EP roundtable event “Ensuring Appropriate Patient Access to PDMPs”

Keynote Address – Admiral Brett Giroir, MD, U.S. HHS Assistant Secretary for Health

Keynote Address – Stella Kyriakides, European Commissioner for Health and Food Safety

Combating COVID-19 Industry Spotlight: Kedrion

Patient Perspectives on COVID-19 and Access to Care

Experts on Coronavirus: The Virus, The Disease, Prevention and Treatment

Plasma: An Overview

Combating COVID-19 Industry Spotlight: Grifols

Combating COVID-19 Industry Spotlight: Emergent

Combating COVID-19 Industry Spotlight: CoVIg-19 Plasma Alliance

Welcome to the Global Plasma Summit

Plasma 101

Spotlight on Plasma Part One: Together We Are Stronger

Ensuring Appropriate Patient Access to Plasma-Derived Medicinal Products

PPTA webinar on unique patient access challenges to plasma-derived medicinal products in COVID times link

Thank you, plasma donors!

From PPTA: "Thank you, plasma donors!"

Prof. Lieven Annemans Speaks about the Value of Plasma-Derived Therapies

The Power of Plasma Donation - Hungarian

The Power of Plasma Donation - Spanish

The Power of Plasma Donation - Czech

The Power of Plasma Donation - German
.jpg)
The Power of Plasma Donation Animation - English

Yes, you can donate source plasma after getting the COVID vaccine

Yes, you can donate source plasma after getting the COVID vaccine

Zika Virus and Plasma Protein Therapies

Zika Virus and Plasma Protein Therapies

Summary of the PPTA/FDA Liaison Meeting (November 8, 2023)

Summary of the PPTA/FDA Liaison Meeting (November 8, 2023)

Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being

Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being

Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID

Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID

Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus

Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus

Sharing the Lifesaving Impact of Plasma Donation During International Plasma Awareness Week 2024

Sharing the Lifesaving Impact of Plasma Donation During International Plasma Awareness Week 2024

Statement on Update on Safety of Albumin

Statement on Update on Safety of Albumin

PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation

PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation

PPTA Responds to The Guardian Article

PPTA Responds to The Guardian Article

PPTA Responds to SoHO Regulation Compromise

PPTA Responds to SoHO Regulation Compromise

PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report

PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report

PPTA Recognizes Essential Contributions of Plasma Donors

PPTA Recognizes Essential Contributions of Plasma Donors

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

PPTA Statement on the Revision of the General EU Pharmaceutical Legislation

PPTA Statement on the Revision of the General EU Pharmaceutical Legislation

PPTA Repeats Appeals for Plasma Donations

PPTA Repeats Appeals for Plasma Donations

PPTA Recognizes 8th Annual International Rare Disease Day

PPTA Recognizes 8th Annual International Rare Disease Day

PPTA Leadership Update – Amy Efantis

PPTA Leadership Update – Amy Efantis
.webp)
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
.webp)
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)

PPTA Statement on the 22nd Edition of the EDQM Blood Guide

PPTA Statement on the 22nd Edition of the EDQM Blood Guide

Professor Isabelle Meyts Honored with the 2025 Joachim Hilfenhaus Award

Professor Isabelle Meyts Honored with the 2025 Joachim Hilfenhaus Award

PPTA Regards SoHO Adoption a Step Forward to Strengthen Donor Protection and Plasma Supply in the EU

PPTA Regards SoHO Adoption a Step Forward to Strengthen Donor Protection and Plasma Supply in the EU

PPTA Press Release on the EU Parliament's ENVI Committee Vote on the SoHO Regulation

PPTA Press Release on the EU Parliament's ENVI Committee Vote on the SoHO Regulation

PPTA Recognizes World Hemophilia Day 2014

PPTA Recognizes World Hemophilia Day 2014

PPTA Statement on the draft EU Substances of Human Origin Regulation

PPTA Statement on the draft EU Substances of Human Origin Regulation

PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation

PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation

PPTA Statement on FDA Guidance Documents

PPTA Statement on FDA Guidance Documents

PPTA’s New Staff Members Aim to Further Plasma Sector Innovation and Advocacy

PPTA’s New Staff Members Aim to Further Plasma Sector Innovation and Advocacy

PPTA Welcomes Sharon Pearce as New Vice President, Lead of Government Affairs

PPTA Welcomes Sharon Pearce as New Vice President, Lead of Government Affairs

PPTA Statement on Immunoglobulin Use to Meet Clinical Need

PPTA Statement on Immunoglobulin Use to Meet Clinical Need

PPTA Welcomes EMA Regulatory Update on vCJD

PPTA Welcomes EMA Regulatory Update on vCJD

PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses

PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses

PPTA Recognizes World Hemophilia Day–April 17, 2015

PPTA Recognizes World Hemophilia Day–April 17, 2015

PPTA Statement on the Ukraine Crisis

PPTA Statement on the Ukraine Crisis

PPTA Statement on Issuance of the EU Critical Medicines List

PPTA Statement on Issuance of the EU Critical Medicines List

PPTA Statement on Review of Donor Blood Pressure Requirements

PPTA Statement on Review of Donor Blood Pressure Requirements

PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”

PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”

PPTA Statement and Reflection on the Quebec Biovigilance Committee’s 8th Biovigilance Forum

PPTA Statement and Reflection on the Quebec Biovigilance Committee’s 8th Biovigilance Forum

PPTA Statement on the Urgent Need for Plasma Donation

PPTA Statement on the Urgent Need for Plasma Donation

PPTA Statement on Review of Donor Weight Loss Monitoring

PPTA Statement on Review of Donor Weight Loss Monitoring

PPTA Statement on MSM Donor Policy

PPTA Statement on MSM Donor Policy

PPTA Responds to ProPublica Article

PPTA Responds to ProPublica Article

Plasma Protein Forum Prepares to “Taking Steps Toward a Better Tomorrow”

Plasma Protein Forum Prepares to “Taking Steps Toward a Better Tomorrow”

Plasma Donors Should be Celebrated, not Denigrated

Plasma Donors Should be Celebrated, not Denigrated
.png)
Plasma Powers Possibility: International Plasma Awareness Week Returns October 6-10
.png)
Plasma Powers Possibility: International Plasma Awareness Week Returns October 6-10

Plasma-Derived Therapies Provide Significant Health Value Gain

Plasma-Derived Therapies Provide Significant Health Value Gain

PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act

PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act

PPTA Disagrees with Ruling from Romanian Competition Council

PPTA Disagrees with Ruling from Romanian Competition Council
PPTA Welcomes Recognition of Pharmaceutical Supply Chain Diversity in EP Rapporteur’s Draft Report on the Critical Medicines Act
PPTA Welcomes Recognition of Pharmaceutical Supply Chain Diversity in EP Rapporteur’s Draft Report on the Critical Medicines Act

PPTA Recognizes First Plasma Collection Centers Certified in Hungary

PPTA Recognizes First Plasma Collection Centers Certified in Hungary
Plasma Protein Forum: Navigating the Winds of Change
Plasma Protein Forum: Navigating the Winds of Change

PPTA Names Amy Efantis President & CEO

PPTA Names Amy Efantis President & CEO

PPTA Responds to Recent Approval of Recombinant Albumin in China

PPTA Responds to Recent Approval of Recombinant Albumin in China

New York and California recognize the importance of plasma donation

New York and California recognize the importance of plasma donation

Monkeypox Virus and Plasma-derived Medicinal Products

Monkeypox Virus and Plasma-derived Medicinal Products

New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs

New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs
%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.webp)
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.webp)
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies

Monkeypox Virus and Plasma Protein Therapies

Monkeypox Virus and Plasma Protein Therapies

Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients

Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients

Marilena Vrana Selected to Lead PPTA’s European Efforts

Marilena Vrana Selected to Lead PPTA’s European Efforts

National and EU Stockpiling Requirements Do Not Ensure Equitable Access to Plasma-Derived Medicinal Products

National and EU Stockpiling Requirements Do Not Ensure Equitable Access to Plasma-Derived Medicinal Products

International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases

International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases

Human Parvovirus PARV4 and plasma protein therapies

Human Parvovirus PARV4 and plasma protein therapies

Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma

Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma

Ebola Virus and Plasma Protein Therapies

Ebola Virus and Plasma Protein Therapies

IPPC 2025 Set to Honor Two Decades of Progress Within a Critical Global Plasma Supply Chain

IPPC 2025 Set to Honor Two Decades of Progress Within a Critical Global Plasma Supply Chain

EPA: Czech Registry is Positive Step in Ensuring Donor Safety

EPA: Czech Registry is Positive Step in Ensuring Donor Safety

A Note to U.S. Plasma Donors on the Spread of Coronavirus

A Note to U.S. Plasma Donors on the Spread of Coronavirus

A missed opportunity to acknowledge EU’s dependency on U.S. plasma

A missed opportunity to acknowledge EU’s dependency on U.S. plasma
European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines
European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines

International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today

International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today

Calling on EU Policymakers to Increase Plasma Donations

Calling on EU Policymakers to Increase Plasma Donations

EU Health Commissioner says plasma donation plays a vital role

EU Health Commissioner says plasma donation plays a vital role

EU Health Commissioner Says Plasma Donation is “More Important Than Ever”

EU Health Commissioner Says Plasma Donation is “More Important Than Ever”

Alabama Lowers Minimum Donation Age to 18

Alabama Lowers Minimum Donation Age to 18

International Plasma Awareness Week 2021: Donate Plasma. Save Lives.

International Plasma Awareness Week 2021: Donate Plasma. Save Lives.

Dr. Charlotte Cunningham-Rundles Wins 2024 Joachim Hilfenhaus Award for Immunology Excellence

Dr. Charlotte Cunningham-Rundles Wins 2024 Joachim Hilfenhaus Award for Immunology Excellence

International Plasma Awareness Week 2022: Donate Locally. Think Globally.

International Plasma Awareness Week 2022: Donate Locally. Think Globally.

Human Plasma Donations Remain Important During COVID-19 Pandemic

Human Plasma Donations Remain Important During COVID-19 Pandemic

Ensuring Access to Medicines for Patients

Ensuring Access to Medicines for Patients
Plasma is Life podcast series episode 5: Nancy Di Salvo, GBS|CIDP Foundation
Plasma is Life podcast series episode 6: Peter Jaworski, Georgetown University
Plasma is Life podcast series episode 4: Vicki & Fred Modell, Co-Founders, Jeffrey Modell Foundation
Plasma is Life podcast series episode 2: U.S. Election 2020 Wrap-Up
.png)
Voices of Hope: Patients Share the Power of Plasma Donations
.png)
Voices of Hope: Patients Share the Power of Plasma Donations

The Value of PPTA Membership In An Evolving Industry: A Conversation with David Bell & Anita Brikman

The Value of PPTA Membership In An Evolving Industry: A Conversation with David Bell & Anita Brikman

Visit PlasmaWeek.org for Free IPAW Resources and More!

Visit PlasmaWeek.org for Free IPAW Resources and More!

Voices of Health Professionals in Treating Patients with Plasma-Derived Medicines

Voices of Health Professionals in Treating Patients with Plasma-Derived Medicines

What Does It Mean To Be Both a Caregiver and An Advocate?

What Does It Mean To Be Both a Caregiver and An Advocate?

Share Powerful Stories During #IPAW2024

Share Powerful Stories During #IPAW2024
Sharing the Power of Plasma on Capitol Hill
Sharing the Power of Plasma on Capitol Hill

Step Inside the 20th International Plasma Protein Congress: Central Theme, Speakers, and What’s New

Step Inside the 20th International Plasma Protein Congress: Central Theme, Speakers, and What’s New

Stepping Inside a Plasma Fractionation Plant: How Human Plasma Becomes Life-Saving Medicine

Stepping Inside a Plasma Fractionation Plant: How Human Plasma Becomes Life-Saving Medicine

Read PPTA’s 2025 Mid-Year Impact Report

Read PPTA’s 2025 Mid-Year Impact Report

Stay Connected on Social Media During #IPAW2024

Stay Connected on Social Media During #IPAW2024

The Problem with Mandatory Stockpiling of Plasma-Derived Medicines in the European Union

The Problem with Mandatory Stockpiling of Plasma-Derived Medicines in the European Union

Share Your #IPAW2024 Feedback

Share Your #IPAW2024 Feedback
.png)
Plasma Powers Possibility: IPAW 2025 Brings Global Attention to Plasma Donation and Patient Access
.png)
Plasma Powers Possibility: IPAW 2025 Brings Global Attention to Plasma Donation and Patient Access

Putting Advocacy In Action During IPAW and Beyond

Putting Advocacy In Action During IPAW and Beyond

Plasma Patients Urge Support for Congressional Plasma Caucus

Plasma Patients Urge Support for Congressional Plasma Caucus

PPTA Unveils Program for IPPC 2024

PPTA Unveils Program for IPPC 2024

Maximize Your Experience at the 20th International Plasma Protein Congress in Warsaw

Maximize Your Experience at the 20th International Plasma Protein Congress in Warsaw

Navigating Challenges and Opportunities in the Plasma Protein Therapeutics Industry: A Discussion with Anita Brikman and Giles Platford

Navigating Challenges and Opportunities in the Plasma Protein Therapeutics Industry: A Discussion with Anita Brikman and Giles Platford

IPAW Reflections: Words of Appreciation for the Lifesaving Impact of Plasma Donors

IPAW Reflections: Words of Appreciation for the Lifesaving Impact of Plasma Donors

From Patient to Provider: Laura’s Story

From Patient to Provider: Laura’s Story

2023 Annual Report

2023 Annual Report

Decorate Your Space for #IPAW2024!

Decorate Your Space for #IPAW2024!
International Plasma Awareness Week is Almost Here!
International Plasma Awareness Week is Almost Here!

A Mid-Year Message from PPTA President and CEO Anita Brikman

A Mid-Year Message from PPTA President and CEO Anita Brikman

IPAW In Focus: Prioritizing Donor Safety

IPAW In Focus: Prioritizing Donor Safety
.png)
International Plasma Awareness Week: Plasma is a Critical Lifeline for Patients
.png)
International Plasma Awareness Week: Plasma is a Critical Lifeline for Patients

Experience IPPC’s 20th Anniversary as if you were seated in the front row!

Experience IPPC’s 20th Anniversary as if you were seated in the front row!

Access to Plasma-Derived Medicines: A Lifesaving Resource for Patients

Access to Plasma-Derived Medicines: A Lifesaving Resource for Patients

"It's like a family reunion" - IPPC Attendees Share What Makes the Congress Special

"It's like a family reunion" - IPPC Attendees Share What Makes the Congress Special

Changing Minds, Changing Lives: The Importance of Raising Awareness for Plasma Donation

Changing Minds, Changing Lives: The Importance of Raising Awareness for Plasma Donation

A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time

A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time
PPTA Podcast
Erfahren Sie mehr darüber, warum Plasma Leben bedeutet – in unseren Podcasts mit einer Vielzahl von Expert:innen.

Plasma is Life podcast series episode 4: Vicki & Fred Modell, Co-Founders, Jeffrey Modell Foundation

Plasma is Life podcast series episode 5: Nancy Di Salvo, GBS|CIDP Foundation

Plasma is Life podcast series episode 6: Peter Jaworski, Georgetown University
PPTA EVENTS
Bleiben Sie über unsere Veranstaltungen auf dem Laufenden, knüpfen Sie Kontakte in unserer großen Community und engagieren Sie sich aktiv.
International Plasma Awareness Week (IPAW) 2025
Erfahren Sie mehr über die Internationale Plasma-Awareness-Woche, die Bedeutung der Plasmaspende, die Patienten und Familien, die auf Plasmaspenden angewiesen sind, und vieles mehr.
PPTA Plasma Protein Forum 2025
Das Plasma Protein Forum ist die wichtigste Konferenz für die Plasmaproteintherapiebranche in Nordamerika. Es bringt Industrie, politische Entscheidungsträger:innen, Dienstleister:innen, Wissenschaftler:innen und Patient:innen zusammen, um mehr über wichtige Themen zu diskutieren.
PPTA Business Forum 2025
Das PPTA Business Forum ist eine Veranstaltung nur für Mitglieder, die vom Vorstand und den Mitarbeiter:innen präsentiert wird, um die Mitglieder besser zu informieren und stärker in die PPTA-Aktivitäten einzubinden.
PPTA International Plasma Protein Congress (IPPC)
Der Internationale Plasmaproteinkongress bringt politische Entscheidungsträger, Interessenvertreter, Patientengruppen und die Industrie in Europa zusammen, um die Notwendigkeit einer verstärkten Plasmagewinnung, regulatorische und politische Entwicklungen sowie die Patientengesundheit und Spendersicherheit zu diskutieren.


ADVOCACY TOOLKITs
Dieses Toolkit bietet eine zentrale Anlaufstelle für Patient:innengruppen und Mitglieder von Organisationen, die an Plasmaproteintherapien interessiert sind. Du kannst diese Informationen nutzen, um deine eigenen Interessenvertretungsbemühungen zu formulieren, deine Anhänger:innen zu informieren und deine Kommunikation zu stärken.
International Plasma Awareness Week toolkit (IPAW)
Als Initiative von PPTA und den Mitgliedsunternehmen zielt die IPAW darauf ab, das Bewusstsein für Plasma zu schärfen und den Beitrag von Plasmaspender:innen zu würdigen. Dieses Toolkit wurde entwickelt, um Ressourcen zur Verfügung zu stellen, mit denen Veranstaltungen wie die IPAW organisiert und bekannt gemacht werden können.
Social media kit
Die Social-Media-Kanäle der PPTA dienen dazu, die Öffentlichkeit zu informieren und mit politischen Entscheidungsträger:innen und Patient:innenorganisationen in Kontakt zu treten, während wir uns für den Zugang zu Plasmaproteintherapien einsetzen. Dieses Toolkit bietet Captions und einfach zu postende Social Media Assets, um diese Arbeit täglich zu unterstützen.
Plasma advocacy material
Dieses Toolkit bietet eine zentrale Anlaufstelle für Patient:innen, die sich für Plasmaproteintherapien interessieren. Hier kannst du dich über die Arbeit von PPTA in Europa und den USA informieren und dich mit anderen Patient:innengruppen und Verbraucher:innenorganisationen vernetzen.




























































